HROW רווח נקי למניה (EPS TTM) Harrow, Inc.

The rolling net income per share snapshot for Harrow, Inc. (HROW) on GURU.Markets demonstrates the efficiency of its licensing and direct sales model for ophthalmological products. The value -0.78 reflects the metric's baseline, confirming the brand's expansion through acquisitions and new approvals. Meanwhile, the financial result relies on cataract surgery volumes and current prescription manufacturing legislation.

Amid intense competition with medical behemoths and the expansion of generics, Harrow, Inc. (HROW) is forced to optimize margins to maintain its market position. The trend in fundamental TTM earnings per share, which aggregates annual data without quarterly gaps, allows for a real-time assessment of capital generation efficiency per share, confirming the business's resilience in the face of industry risks and market traps.